Jeppe Friborg

MD PhD Dept. of Oncology, Rigshospitalet, Copenhagen jeppe.friborg@regionh.dk
Forskningsområde Arbejdsgrupper Publikationer
  • Kjems J, Zukauskaite R, Johansen J, Eriksen JG, Lassen P, Andersen E, Andersen M, Farhadi M, Overgaard J, Vogelius IR, Friborg J Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study Acta Oncol. 2021 Nov;60(11):1472-1480 2021
  • Sharma MB, Jensen K, Friborg J, Smulders B, Andersen E, Samsøe E, Johansen J, Hansen CR, Andersen M, Nielsen MS, Filtenborg MV, Ren J, Korreman SS, Overgaard J, Grau C Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008-2015. A DAHANCA study Acta Oncol . 2022 Feb;61(2):120-126 2022
  • Kristian Hastoft Jensen Ivan Vogelius, Claus Ernst Moser , Elo Andersen, Jesper Grau Eriksen, Jørgen Johansen , Mohammad Farhadi, Maria Andersen, Jens Overgaard, Jeppe Friborg Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database Br J Cancer. 2021 Aug;125(3):458-464 2021
  • Kristian Hastoft Jensen, Ivan Richter Vogelius, Mogens Bernsdorf, Anita Gothelf, Claus Andrup Kristensen, Christian Maare , Elo Andersen, Lena Specht, Jeppe Friborg Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma Radiother Oncol. 2022 Jun;171:1-6 2022
  • Håkansson K, Smulders B, Specht L, Zhu M, Friborg J, Rasmussen JH, Bentzen SM, Vogelius IR. Radiation dose-painting with protons vs. photons for head-and-neck cancer Acta Oncol. 2020 May;59(5):525-533 2020
  • Risør LM, Loft A, Berthelsen AK, Loft FC, Madsen AR, Vogelius IR, Kjær A, Friborg J FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy Eur Arch Otorhinolaryngol. 2020 Feb;277(2):539-547 2020
  • Lindegaard AM, von Buchwald C, Rasmussen JH, Specht L, Vogelius IR, Zamani M, Woller NC, Lelkaitis G, Friborg J Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer. Head Neck. 2020 Jul 18. 2020
  • Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen MS, Eriksen JG, Petersen JBB, Elstrøm UV, Holm AI, Farhadi M, Morthorst MH, Skyt PS, Overgaard J, Grau C The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020 Aug 8;151:149-151. 2020
  • Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg J Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. Clin Oncol (R Coll Radiol) . 2020 Jul 19;S0936-6555(20)30286-7. 2020
  • Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG, Overgaard J NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019 Oct;58(10):1410-1415. 2019
  • Håkansson K, Rasmussen JH, Bentzen SM, Friborg J, Specht L, Vogelius IR On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer. Acta Oncol. 2019 Mar;58(3):390-392. 2019
  • Chan J, Friborg J, Chernov M, Cherkashin M, Grau C, Brundage M, Slotman B Access to radiotherapy among circumpolar Inuit populations. Lancet Oncol. 2019 Oct;20(10):e590-e600 2019
  • Kovacs DG, Rechner LA, Appelt AL, Berthelsen AK, Costa JC, Friborg J, Persson GF, Bangsgaard JP, Specht L, Aznar MC. Metal artefact reduction for accurate tumour delineation in radiotherapy. Radiother Oncol. 2018 Mar;126(3):479-486 2017
  • Scott SI, Kathrine Ø Madsen A, Rubek N, Charabi BW, Wessel I, Fredslund Hadjú S, Jensen CV, Stephen S, Patterson JM, Friborg J, Hutcheson KA, Kehlet H, von Buchwald C. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer. Cancer Med. 2021 Jan;10(2):483-495 2020
  • Chan J, Friborg J, Zubizarreta E, van Eck JW, Hanna TP, Bourque JM, Gaudet M, Dennis K, Olson R, Coleman CN, Petersen AJ, Grau C, Abdel-Wahab M, Brundage M, Slotman B, Polo A Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutions. Radiother Oncol. 2020 May;146:1-8 2020
  • Laursen M, Specht L, Kristensen CA, Gothelf A, Bernsdorf M, Vogelius I, Friborg J An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas. Front Oncol. 2018 Jun 11;8:206 2018
  • Scott SI, Madsen AKØ, Rubek N, Charabi BW, Wessel I, Jensen CV, Friborg J, von Buchwald C Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy. 2022